title: A route to new cancer therapies: the FA pathway is essential in BRCA1- or BRCA2-deficient cells.
authors.affiliation: MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee, Scotland, UK.
authors.forename: Christophe
authors.initials: C
authors.lastname: Lachaud
authors.affiliation: MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee, Scotland, UK.
authors.forename: John
authors.initials: J
authors.lastname: Rouse
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics / Q000378:metabolism*; D024682:BRCA2 Protein / Q000235:genetics / Q000378:metabolism*; D001943:Breast Neoplasms / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D052236:Fanconi Anemia Complementation Group D2 Protein / Q000235:genetics / Q000378:metabolism*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D010051:Ovarian Neoplasms / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy
chemical_list: D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human; C499905:FANCD2 protein, human; D052236:Fanconi Anemia Complementation Group D2 Protein; D050505:Mutant Proteins